Airlift Bioreactors Global Market Report 2026

Airlift bioreactors are vertical tower reactors designed to facilitate large-scale aerobic cultures, utilizing an airlift pump to infuse gas into the culture broth for effective mixing. They find application in cultivating microorganisms, plant, and animal cells, particularly in sectors such as pharmaceuticals, enzyme production, and biofuels.

There are two primary types of airlift bioreactors, internal airlift loop bioreactors and external airlift loop bioreactors. The internal airlift loop bioreactor features a single vessel divided into interconnected zones-the riser and the downcomer-allowing for the circulation of liquid. These bioreactors come in various capacities, including 5 liters, 7 liters, 10 liters, and 30 liters, catering to different needs such as single-use, disposable, or reusable setups. They are deployed across laboratory, pilot, and large scales, serving diverse end-users such as biopharmaceutical companies, contract research organizations (CROs) or contract development and manufacturing organizations (CDMOs), as well as research and development firms.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the airlift bioreactors market by increasing costs of imported stainless steel vessels, precision sensors, control systems, and specialized fabrication components used in laboratory, pilot, and large-scale reactors. Biopharmaceutical and biotechnology hubs in North America and Europe are most affected due to reliance on imported high-grade materials, while Asia-Pacific faces cost pressure on export-oriented equipment manufacturing. These tariffs are raising capital expenditure and extending procurement timelines. However, they are also encouraging localized equipment fabrication, regional supplier development, and innovation in cost-efficient and modular airlift bioreactor designs.

The airlift bioreactors market research report is one of a series of new reports from The Business Research Company that provides airlift bioreactors market statistics, including airlift bioreactors industry global market size, regional shares, competitors with a airlift bioreactors market share, detailed airlift bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the airlift bioreactors industry. This airlift bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The airlift bioreactors market size has grown strongly in recent years. It will grow from $4.32 billion in 2025 to $4.75 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing capacity, increased use of microbial fermentation processes, growth in enzyme and biofuel production, rising adoption of disposable bioprocessing systems, advancements in large-scale cell culture techniques.

The airlift bioreactors market size is expected to see strong growth in the next few years. It will grow to $6.71 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for biologics and vaccines, rising investments in sustainable bio-manufacturing, expansion of contract manufacturing services, growing focus on process intensification, increasing adoption of smart bioreactor control systems. Major trends in the forecast period include increasing adoption of single-use airlift bioreactor systems, rising demand for large-scale aerobic fermentation solutions, growing integration of advanced process monitoring sensors, expansion of modular and scalable bioreactor designs, enhanced focus on energy-efficient mixing mechanisms.

The rising demand for biopharmaceutical products is expected to drive growth in the airlift bioreactors market going forward. Biopharmaceutical products are therapeutic agents derived from living organisms or produced through biotechnological methods, including recombinant DNA technology, cell cultures, and monoclonal antibodies. Demand is growing due to advancements in cell culture technologies, the rising prevalence of chronic and age-related diseases, innovations in bioprocessing, and progress in genomics. Airlift bioreactors offer significant advantages in producing therapeutic proteins, monoclonal antibodies, and vaccines. For instance, in August 2023, the Alliance for Regenerative Medicine, a US-based non-profit organization, reported 2,760 cell, gene, and tissue-engineering therapeutic developers worldwide in Q1 2023, a 101% increase from 1,369 in Q1 2022. Therefore, growing demand for biopharmaceutical products is propelling the airlift bioreactors market.

Companies in the airlift bioreactor market are emphasizing cloud-integrated systems to improve process efficiency, automation, and remote monitoring. Cloud-integrated bioreactors combine physical equipment with real-time monitoring, automated controls, and AI-driven optimization, allowing bioprocess teams to manage experiments more precisely and efficiently. For example, in April 2025, Culture Biosciences, a US-based company supporting biotech process development in the cloud, launched the Stratyx 250, a mobile, cloud-integrated bioreactor. The system provides cart-based mobility for lab relocation, integrates Culture Console software for real-time monitoring and automation, and uses single-use technology to minimize cleaning and downtime. Stratyx 250 also leverages AI and machine learning to optimize bioprocesses, achieving 25% faster development timelines, 30% improved scale-up success, and a 16% reduction in total cost per run. It can be used with a Cytiva 250 mL consumable that replicates large-scale reactor conditions on a smaller platform, supporting efficient process development and faster optimization.

In September 2025, Morimatsu Group, a Japan-based engineering firm, acquired Bioengineering AG for an undisclosed amount. This acquisition enables Morimatsu to strengthen its airlift bioreactor capabilities by integrating Bioengineering's bioreactor and fermentation technologies and expanding its advanced bioprocess equipment portfolio. Bioengineering AG is a Switzerland-based manufacturer of bioreactor and fermentation equipment, providing proven airlift and stirred-tank bioreactor systems for industrial and research applications.

Major companies operating in the airlift bioreactors market are Sartorius AG, Cytiva, Applikon Biotechnology B.V., Cellexus International Ltd, Bionet Innovacion S.L., Solida Biotech GmbH, Belach Bioteknik AB, OmniBRx Biotechnologies Pvt. Ltd., Electrolab Biotech Ltd., LABOAO Instrument Equipment Co. Ltd., Bailun Biotechnology Co. Ltd., BioReactor Sciences Inc., Shree Biocare Solutions Pvt. Ltd., Lab1st Scientific Co. Ltd., Cedarstone Industry LLC, New Brunswick Scientific Co. Inc., Eppendorf AG, Kuhner AG, Thermo Fisher Scientific Inc., Lonza Group AG, ABEC Inc., Pierre Guerin SAS, Bioengineering AG

North America was the largest region in the airlift bioreactor market in 2025. The regions covered in the airlift bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the airlift bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The airlift bioreactor market consists of sales of stainless steel and glass airlift bioreactors, bioplastics, bioactive compounds, level sensors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Airlift Bioreactors Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses airlift bioreactors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for airlift bioreactors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The airlift bioreactors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Internal Airlift Loop Bioreactor; External Airlift Loop Bioreactor
• 2) By Capacity: 5 Liters; 7 Liters; 10 Liters; 30 Liters
• 3) By Usage: Single-Use Or Disposal; Reusable
• 4) By Production Scale: Laboratory Scale; Pilot-Scale; Large Scale
• 5) By End-User: Biopharmaceutical Companies; Contract Research Organizations (CROs) Or Contract Development And Manufacturing Organizations (CDMOs); Research And Development Companies
• Subsegments:
• 1) By Internal Airlift Loop Bioreactor: Circulating Bioreactor; Non-Circulating Bioreactor
• 2) By External Airlift Loop Bioreactor: Single-Stage External Airlift Bioreactor; Multi-Stage External Airlift Bioreactor
• Companies Mentioned: Sartorius AG; Cytiva; Applikon Biotechnology B.V.; Cellexus International Ltd; Bionet Innovacion S.L.; Solida Biotech GmbH; Belach Bioteknik AB; OmniBRx Biotechnologies Pvt. Ltd.; Electrolab Biotech Ltd.; LABOAO Instrument Equipment Co. Ltd.; Bailun Biotechnology Co. Ltd.; BioReactor Sciences Inc.; Shree Biocare Solutions Pvt. Ltd.; Lab1st Scientific Co. Ltd.; Cedarstone Industry LLC; New Brunswick Scientific Co. Inc.; Eppendorf AG; Kuhner AG; Thermo Fisher Scientific Inc.; Lonza Group AG; ABEC Inc.; Pierre Guerin SAS; Bioengineering AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.